High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR Imaging

被引:388
作者
Law, M
Cha, S
Knopp, EA
Johnson, G
Arnett, J
Litt, AW
机构
[1] NYU, Med Ctr, Dept Radiol, New York, NY 10016 USA
[2] NYU, Med Ctr, Dept Neurosurg, New York, NY 10016 USA
关键词
brain neoplasms; diagnosis; MR; secondary; magnetic resonance (MR); spectroscopy; perfusion study;
D O I
10.1148/radiol.2223010558
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine whether perfusion-weighted and proton spectroscopic MR imaging can be used to differentiate high-grade primary gliomas and solitary metastases on the basis of differences in vascularity and metabolite levels in the peritumoral region. MATERIALS AND METHODS: Fifty-one patients with a solitary brain tumor (33 gliomas, 18 metastases) underwent conventional, contrast material-enhanced perfusion-weighted, and proton spectroscopic MR imaging before surgical resection or stereotactic biopsy. Of the 33 patients with gliomas, 22 underwent perfusion-weighted MR imaging; nine, spectroscopic MR imaging; and two underwent both. Of the 18 patients with metastases, 12 underwent perfusion-weighted MR imaging, and six, spectroscopic MR imaging. The peritumoral region was defined as the area in the white matter immediately adjacent to the enhancing (hyperintense on T2-weighted images, but not enhancing on postcontrast T1-weighted images) portion of the tumor. Relative cerebral blood volumes in these regions were calculated from perfusion-weighted MR data. Spectra from the enhancing tumor, the peritumoral region, and normal brain were obtained from the two-dimensional spectroscopic MR acquisition. The Student t test was used to determine if there was a statistically significant difference in relative cerebral blood volume and metabolic ratios between high-grade gliomas and metastases. RESULTS: The measured relative cerebral blood volumes in the peritumoral region in high-grade gliomas and metastases were 1.31 +/- 0.97 (mean +/- SD) and 0.39 +/- 0.19, respectively. The difference was statistically significant (P < .001). Spectroscopic imaging demonstrated elevated choline levels (choline-to-creatine ratio was 2.28 ± 1.24) in the peritumoral region of gliomas but not in metastases (choline-to-creatine ratio was 0.76 ± 0.23). The difference was statistically significant (P = .001). CONCLUSION: Although conventional MR imaging characteristics of solitary metastases and primary high-grade gliomas may sometimes be similar, perfusion-weighted and spectroscopic MR imaging enable distinction between the two. (C) RSNA, 2002.
引用
收藏
页码:715 / 721
页数:7
相关论文
共 24 条
  • [11] MAPPING OF BRAIN-TUMOR METABOLITES WITH PROTON MR SPECTROSCOPIC IMAGING - CLINICAL RELEVANCE
    FULHAM, MJ
    BIZZI, A
    DIETZ, MJ
    SHIH, HHL
    RAMAN, R
    SOBERING, GS
    FRANK, JA
    DWYER, AJ
    ALGER, JR
    DICHIRO, G
    [J]. RADIOLOGY, 1992, 185 (03) : 675 - 686
  • [12] Henry RG, 2000, AM J NEURORADIOL, V21, P357
  • [13] BLOOD-FLOW AND REGULATION OF BLOOD-FLOW IN EXPERIMENTAL PERITUMORAL EDEMA
    HOSSMANN, KA
    BLOINK, M
    [J]. STROKE, 1981, 12 (02) : 211 - 217
  • [14] Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging
    Knopp, EA
    Cha, S
    Johnson, G
    Mazumdar, A
    Golfinos, JG
    Zagzag, D
    Miller, DC
    Kelly, PJ
    Kricheff, II
    [J]. RADIOLOGY, 1999, 211 (03) : 791 - 798
  • [15] CAPILLARY ULTRASTRUCTURE IN HUMAN METASTATIC BRAIN-TUMORS
    LONG, DM
    [J]. JOURNAL OF NEUROSURGERY, 1979, 51 (01) : 53 - 58
  • [16] Analysis of brain tumors using H-1 magnetic resonance spectroscopy
    McBride, DQ
    Miller, BL
    Nikas, DL
    Buchthal, S
    Chang, L
    Chiang, F
    Booth, RA
    [J]. SURGICAL NEUROLOGY, 1995, 44 (02): : 137 - 144
  • [17] POPTANI H, 1995, AM J NEURORADIOL, V16, P1593
  • [18] Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
    Preul, MC
    Caramanos, Z
    Collins, DL
    Villemure, JG
    Leblanc, R
    Olivier, A
    Pokrupa, R
    Arnold, DL
    [J]. NATURE MEDICINE, 1996, 2 (03) : 323 - 325
  • [19] Ricci PE, 2000, AM J NEURORADIOL, V21, P367
  • [20] H-1 MR SPECTROSCOPY IN PATIENTS WITH METASTATIC BRAIN-TUMORS - A MULTICENTER STUDY
    SIJENS, PE
    KNOPP, MV
    BRUNETTI, A
    WICKLOW, K
    ALFANO, B
    BACHERT, P
    SANDERS, JA
    STILLMAN, AE
    KETT, H
    SAUTER, R
    OUDKERK, M
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1995, 33 (06) : 818 - 826